Hexinor directly inhibits the parasympathetic nervous system while also relaxing smooth muscles. This muscle relaxation occurs both directly on muscle tissue and indirectly through the suppression of parasympathetic nervous system activity.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Hexinor tablets are used as a supplementary treatment for all types of Parkinsonism, including postencephalitic, arteriosclerotic, and idiopathic forms. It is particularly beneficial when used alongside levodopa. Additionally, Hexinor helps manage extrapyramidal disorders caused by certain central nervous system (CNS) drugs, including dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.
Use this medication only under the guidance of a registered physician.
Trihexyphenidyl, the active ingredient, is a non-selective muscarinic acetylcholine receptor antagonist with a higher affinity for the M1 subtype. Research indicates that it primarily targets central muscarinic receptors in the cerebral cortex rather than peripheral ones. Some studies suggest it may also influence nicotinic acetylcholine receptor transmission, indirectly increasing dopamine release in the striatum. Despite its effectiveness in treating Parkinson’s disease and other movement disorders, the exact mechanism of action remains unclear.
Dosage should be tailored to individual patient needs. It is generally recommended to start with a low dose and gradually increase it, especially in patients over 60 years of age. The best time to take the medication—before or after meals—depends on the patient's response. Patients experiencing excessive salivation may prefer taking it after meals, sometimes with small amounts of atropine. However, if it causes excessive dry mouth, taking it before meals may be better, unless it leads to nausea. If taken after meals, thirst can be managed with mint candies, chewing gum, or water. Abrupt discontinuation should be avoided as it may cause a worsening of Parkinson’s symptoms or lead to neuroleptic malignant syndrome (NMS).